Non-myeloablative hematopoietic stem cell transplantation in the treatment of severe idiopathic CD4+ lymphocytopenia

European Journal of Haematology

Volumn 87, Issue 1, 2011, Pages 87-91

  Cervera, Carlos ^a   Fernández Avilés, Francesc ^b   de la Calle Martin, Oscar ^c   Bosch, Xavier ^b   Rovira, Montserrat ^b   Plana, Montse ^b,d   Moreno, Asunción ^a   García, Felipe ^a   Miró, Jose M ^a   Martínez, Antonio ^b,d   Gallart, Teresa ^b   Carreras, Enric ^b   Blade, Joan ^b   Gatell, Jose M ^a  

^a Service of Infectious Diseases   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

Allogeneic hematopoietic stem cell transplantation; Idiopathic CD4+ lymphocytopenia; Non myeloablative conditioning

Indexed keywords

COTRIMOXAZOLE; FLUDARABINE; GANCICLOVIR; INTERLEUKIN 2; PROTEIN P56; VALGANCICLOVIR;

ADULT; ANUS FISTULA; ARTICLE; CASE REPORT; CD4+ T LYMPHOCYTE; CD4[+] T LYMPHOCYTE; CELIAC DISEASE; CHIMERA; CHRONIC DISEASE; FOLLOW UP; GLUTEN FREE DIET; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIATUS HERNIA; HLA SYSTEM; HUMAN; INFECTIOUS COMPLICATION; LEUKAPHERESIS; LOW DRUG DOSE; LYMPHOCYTOPENIA; LYMPHOPROLIFERATIVE DISEASE; MALE; OPPORTUNISTIC INFECTION; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; PSORIASIS; WHOLE BODY RADIATION;

ADULT; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA ANTIGENS; HUMANS; MALE; MYELOABLATIVE AGONISTS; T-LYMPHOCYTOPENIA, IDIOPATHIC CD4-POSITIVE; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 80955177495     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2011.01619.x     Document Type: Article

References (20)

1. Duncan RA, von Reyn CF, Alliegro GM, Toossi Z, Sugar AM, Levitz SM. Idiopathic CD4+ T-lymphocytopenia - four patients with opportunistic infections and no evidence of HIV infection. N Engl J Med 1993;328:393-8.
2. Spira TJ, Jones BM, Nicholson JK, et al. Idiopathic CD4+ T-lymphocytopenia - an analysis of five patients with unexplained opportunistic infections. N Engl J Med 1993;328:386-92.
3. Ho DD, Cao Y, Zhu T, et al. Idiopathic CD4+ T-lymphocytopenia - immunodeficiency without evidence of HIV infection. N Engl J Med 1993;328:380-5.
4. Smith DK, Neal JJ, Holmberg SD. Unexplained opportunistic infections and CD4+ T-lymphocytopenia without HIV infection. An investigation of cases in the United States. The Centers for Disease Control Idiopathic CD4+ T-lymphocytopenia Task Force. N Engl J Med 1993;328:373-9.
5. Soriano V, Hewlett I, Heredia A, et al. Idiopathic CD4+ T-lymphocytopenia. Lancet 1992;340:607-8; author reply 9.
6. From the Centers for Disease Control. Update: CD4+ T-lymphocytopenia in persons without evident HIV infection - United States. JAMA 1992;268:1252.
7. Update: CD4+ T-lymphocytopenia in persons without evident HIV infection - United States. MMWR Morb Mortal Wkly Rep 1992;41:578-9. .
8. Zonios DI, Falloon J, Bennett JE, et al. Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors. Blood 2008;112:287-94.
9. Malaspina A, Moir S, Chaitt DG, et al. Idiopathic CD4+ T lymphocytopenia is associated with increases in immature/transitional B cells and serum levels of IL-7. Blood 2007;109:2086-8.
10. Trojan T, Collins R, Khan DA. Safety and efficacy of treatment using interleukin-2 in a patient with idiopathic CD4(+) lymphopenia and Mycobacterium avium-intracellulare. Clin Exp Immunol 2009;156:440-5.
11. Abrams D, Levy Y, Losso MH, et al. Interleukin-2 therapy in patients with HIV infection. N Engl J Med 2009;361:1548-59.
12. Small TN, Papadopoulos EB, Boulad F, et al. Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions. Blood 1999;93:467-80.
13. Zamoyska R, Basson A, Filby A, Legname G, Lovatt M, Seddon B. The influence of the src-family kinases, Lck and Fyn, on T cell differentiation, survival and activation. Immunol Rev 2003;191:107-18.
14. Hubert P, Bergeron F, Ferreira V, et al. Defective p56Lck activity in T cells from an adult patient with idiopathic CD4+ lymphocytopenia. Int Immunol 2000;12:449-57.
15. Reith W, Mach B. The bare lymphocyte syndrome and the regulation of MHC expression. Annu Rev Immunol 2001;19:331-73.
16. Di Sabatino A, Bertrandi E, Casadei Maldini M, Pennese F, Proietti F, Corazza GR. Phenotyping of peripheral blood lymphocytes in adult coeliac disease. Immunology 1998;95:572-6.
17. Laurence J, Mitra D, Steiner M, Lynch DH, Siegal FP, Staiano-Coico L. Apoptotic depletion of CD4+ T cells in idiopathic CD4+ T lymphocytopenia. J Clin Invest 1996;97:672-80.
18. Roger PM, Bernard-Pomier G, Counillon E, Breittmayer JP, Bernard A, Dellamonica P. Overexpression of Fas/CD95 and Fas-induced apoptosis in a patient with idiopathic CD4+ T lymphocytopenia. Clin Infect Dis 1999;28:1012-6.
19. Rao K, Amrolia PJ, Jones A, et al. Improved survival after unrelated donor bone marrow transplantation in children with primary immunodeficiency using a reduced-intensity conditioning regimen. Blood 2005;105:879-85.
20. Petersen EJ, Rozenberg-Arska M, Dekker AW, Clevers HC, Verdonck LF. Allogeneic bone marrow transplantation can restore CD4+ T-lymphocyte count and immune function in idiopathic CD4+ T-lymphocytopenia. Bone Marrow Transplant 1996;18:813-5.